Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease

被引:57
作者
Choi, EY
Christianson, GJ
Yoshimura, Y
Jung, N
Sproule, TJ
Malarkannan, S
Joyce, S
Roopenian, DC
机构
[1] Jackson Lab, Bar Harbor, ME 04609 USA
[2] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA
[3] Blood Res Inst, Dept Med, Milwaukee, WI USA
关键词
D O I
10.1182/blood-2002-05-1299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although CD8 T cells are thought to be a principal effector population of graft-versus-host disease (GVHD), their dynamics and specificity remain a mystery. Using a mouse model in which donor and recipient were incompatible at many minor histocompatibility antigens (minor H Ags), the CD8 T-cell response was tracked temporally and spatially through the course of GVHD. Donor CD8 T cells in the circulation, spleen, lung, and liver demonstrated virtually identical kinetics: rapid expansion and then decline prior to morbidity. Remarkably, up to one fourth of the CD8 T cells were directed against a single minor antigen, H60. Extreme H60 immunodominance occurred regardless of sampling time, site, and genetic background. This study is the first to analyze the T cells participating in GVHD in "real-time," demonstrates the exceptional degree to which immunodominance of H60 can occur, and suggests that such super-dominant minor H Ags could be risk factors for GVHD.
引用
收藏
页码:4259 / 4265
页数:7
相关论文
共 40 条
[21]   Differences that matter: Major cytotoxic T cell-stimulating minor histocompatibility antigens [J].
Malarkannan, S ;
Horng, T ;
Eden, P ;
Gonzalez, F ;
Shih, P ;
Brouwenstijn, N ;
Klinge, H ;
Christianson, G ;
Roopenian, D ;
Shastri, N .
IMMUNITY, 2000, 13 (03) :333-344
[22]  
Malarkannan S, 1998, J IMMUNOL, V161, P3501
[23]   HUMAN MARROW TRANSPLANTATION - AN IMMUNOLOGICAL PERSPECTIVE [J].
MARTIN, PJ ;
HANSEN, JA ;
STORB, R ;
THOMAS, ED .
ADVANCES IN IMMUNOLOGY, 1987, 40 :379-438
[24]   Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue [J].
Masopust, David ;
Vezys, Vaiva ;
Marzo, Amanda L. ;
Lefrancois, Leo .
JOURNAL OF IMMUNOLOGY, 2014, 192 (03) :2413-2417
[25]   Minors held by majors: The H13 minor histocompatibility locus defined as a peptide MHC class I complex [J].
Mendoza, LM ;
Paz, P ;
Zuberi, A ;
Christianson, G ;
Roopenian, D ;
Shastri, N .
IMMUNITY, 1997, 7 (04) :461-472
[26]   Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease [J].
Murai, M ;
Yoneyama, H ;
Harada, A ;
Yi, Z ;
Vestergaard, C ;
Guo, BY ;
Suzuki, K ;
Asakura, H ;
Matsushima, K .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) :49-57
[27]  
Murata M, 2000, INT J HEMATOL, V72, P371
[28]   Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease [J].
Mutis, T ;
Gillespie, G ;
Schrama, E ;
Falkenburg, JHF ;
Moss, P ;
Goulmy, E .
NATURE MEDICINE, 1999, 5 (07) :839-842
[29]   Identification of an immunodominant mouse minor histocompatibility antigen (MiHA) - T cell response to a single dominant MiHA causes graft-versus-host disease [J].
Perreault, C ;
Jutras, J ;
Roy, DC ;
Filep, JG ;
Brochu, S .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :622-628
[30]   On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens [J].
Pion, S ;
Fontaine, P ;
Desaulniers, M ;
Jutras, J ;
Filep, JG ;
Perreault, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) :421-430